Arecor Therapeutics plc (AREC.L)

GBp 38.0

(0.0%)

Operating Expenses Summary of Arecor Therapeutics plc

Arecor Therapeutics plc's latest annual operating expenses in 2023 was 13.74 Million GBP , up 9.41% from previous year.
Arecor Therapeutics plc's latest quarterly operating expenses in 2024 Q2 was 3.41 Million GBP , down 0.0% from previous quarter.
Arecor Therapeutics plc reported a annual operating expenses of 13.03 Million GBP in annual operating expenses 2022, up 82.66% from previous year.
Arecor Therapeutics plc reported a annual operating expenses of 7.13 Million GBP in annual operating expenses 2021, up 39.2% from previous year.
Arecor Therapeutics plc reported a quarterly operating expenses of 3.41 Million GBP for 2024 Q1, down -4.14% from previous quarter.
Arecor Therapeutics plc reported a quarterly operating expenses of 3.56 Million GBP for 2023 Q4, up 0.07% from previous quarter.

Annual Operating Expenses Chart of Arecor Therapeutics plc (2023 - 2017)

Historical Annual Operating Expenses of Arecor Therapeutics plc (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	13.74 Million GBP	9.41%
2022	13.03 Million GBP	82.66%
2021	7.13 Million GBP	39.2%
2020	5.12 Million GBP	11.93%
2019	4.57 Million GBP	27.1%
2018	3.6 Million GBP	31.11%
2017	2.74 Million GBP	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	3.41 Million GBP	0.0%
2024 Q1	3.41 Million GBP	-4.14%
2023 Q4	3.56 Million GBP	0.07%
2023 FY	14.25 Million GBP	9.41%
2023 Q2	6.93 Million GBP	109.3%
2023 Q3	3.55 Million GBP	-48.65%
2023 Q1	3.31 Million GBP	-56.21%
2022 Q2	6.26 Million GBP	111.48%
2022 Q1	2.96 Million GBP	-36.75%
2022 Q4	7.56 Million GBP	116.27%
2022 FY	13.03 Million GBP	82.66%
2022 Q3	3.49 Million GBP	-44.15%
2021 Q3	2.08 Million GBP	-38.34%
2021 Q2	3.38 Million GBP	73.3%
2021 FY	7.13 Million GBP	39.2%
2021 Q1	1.95 Million GBP	-35.35%
2021 Q4	4.68 Million GBP	124.22%
2020 Q3	1.48 Million GBP	-37.76%
2020 Q2	2.38 Million GBP	121.29%
2020 Q1	1.07 Million GBP	0.0%
2020 FY	5.12 Million GBP	11.93%
2020 Q4	3.02 Million GBP	103.31%
2019 FY	4.57 Million GBP	27.1%
2018 FY	3.6 Million GBP	31.11%
2017 FY	2.74 Million GBP	0.0%

Peer Operating Expenses Comparison of Arecor Therapeutics plc

Name	Operating Expenses	Operating Expenses Difference